- ZIOPHARM Oncology (ZIOP +7.8%) Q3 results: Revenues: $633K (+216.5%); R&D Expense: $9.7M (+56.5%); SG&A: $2.8M (-9.7%); Operating Loss: $(11.9M) (-30.8%); Net Loss: $(6.1)M (+63.5%); EPS: $-0.06 (+70.0%); Quick Assets: $46.1M (-32.4%).
- No guidance given.
More on Ziopharm Q3 results
Recommended For You
About TCRT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TCRT | - | - |
| Alaunos Therapeutics, Inc. | ||